comparemela.com

Latest Breaking News On - Deciphera pharmaceuticals - Page 9 : comparemela.com

INVESTIGATION: The M&A Class Action Firm Announces An Investigation of Deciphera Pharmaceuticals, Inc - DCPH

NEW YORK, April 29, 2024 /PRNewswire/ Monteverde & Associates PC , has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services.

Ono to Expand Cancer Portfolio with $2 4B Deciphera Acquisition

Ono to Expand Cancer Portfolio with $2 4B Deciphera Acquisition
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Deciphera to sell for $2 4B, adding to upswing in biopharma M&A

DCPH Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Deciphera Pharmaceuticals, Inc Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Deciphera Pharmaceuticals, Inc. to ONO Pharmaceutical Co., Ltd. for $25.60 per share in cash is fair to Deciphera.

Deciphera Up In Pre-market On News Of Acquisition By ONO Pharmaceutical For About $2 4 Bln

Shares of Deciphera Pharmaceuticals, Inc. (DCPH) were surging more than 70 percent in pre-market on Monday to $25.03 after the company announced its decision to be acquired by ONO Pharmaceutical Co.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.